| ²é¿´: 3011 | »Ø¸´: 32 | |||||||||||||||||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß redkey65 µÄ 23 ¸ö½ð±Ò £¬»ØÌû¾ÍÁ¢¼´»ñµÃ 1 ¸ö½ð±Ò£¬Ã¿ÈËÓÐ 1 ´Î»ú»á | |||||||||||||||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||||||||||||||||
[½»Á÷]
»ÔÈðÎ人Ñз¢ÖÐÐijÏÕÐÁÙ´²ÊÔÑéÖúÀí£¨ÄÚ²¿ÍƼö£©¼±ÕÐ6ÈË£¡
|
|||||||||||||||||
ÎÒÃÇÊÇÕâÀ»ÔÈðÎ人Ñз¢ÖÐÐÄ×øÂäÓÚ·ç¾°ÓÅÃÀµÄ¹â¹ÈÉúÎï³Ç£¬Ä¿Ç°ÓÐ700+Ô±¹¤¡£Ð½×ʸ£Àû²»»á²î£¬¿É°Ù¶ÈÁ˽⡣ ÎÒÃÇÔÚÕâÀÎÒÃÇÊÇÓзç¶ÈÒ²ÓÐζȵÄteam£¬manager³¬¼¶nice¡£½üÆÚÒµÎñSample TextÀ©ÕÅ£¬ÓÐ6¸ö¿Õȱְ룬¼±ÐèÈË¡£»¶Ó¸÷λӻԾ×Ô¼ö»òÍÆ¼ö¡£ ÎÒÃÇÆÚ´ýÄ㣬¼È¶ÁµÃ¶®Ó¢ÎÄÎÄÏ×£¬Óֻظ´µÃÁËÓ¢ÎÄÓʼþ¡£Ó¢ÎĶÁд²»³ÉÎÊÌ⣻¿´²»Ì«¶®ÏÂÃæµÄÖ°ÎñÃèÊöû¹ØÏµ£¬ÎÒÃÇÓÐÍêÉÆµÄÅàѵ»úÖÆÀ´°ïÖúÄã¿ìËÙÁ˽⡣ ÎÒÃÇÏ£ÍûÄ㣬ÄÚÏòÍâÏò¶¼ok£¬Ö»ÒªÄܾ²ÏÂÐÄÀ´×öÊÂÇ飬ϲ»¶°ì¹«ÊҰ칫ģʽ¼´¿É£¬Õ¾×Å»ò×ø×ÅËæÒâ¡£ÆäËûµÄ¿´ÑÛÔµ°É£¬Ëµ²»¶¨ÎÒÃǾͱ˴˿´¶ÔÑÛÇ©offerÁËÄØ¡£ ÎÒÃǰïÖúÄ㣬ȫ·½Î»Á˽âÁÙ´²ÊÔÑéµÄÕû¸öÁ÷³Ì£¬Ö¾´æ¸ßÔ¶µÄÄ㻹¿ÉÒÔ´ÓÖúÀíÆð²½£¬×öµ½ÏîÄ¿¾ÀíStudy Manager/ Clinical Project ManagerÖ¸ÈÕ¿É´ýѽ¡£ ¹¤×÷ÀàÐÍ£º ÕýʽԱ¹¤ / Regular ÁªÏµ·½Ê½: redkey3@sina.com£»ÖÐÓ¢ÎļòÀú¾ù¿É£¬Ó¦½ìÍù½ì¶¼»¶Ó£¡ »ù±¾Á÷³Ì£º ¼òÀúÍÆ¼ö---°²ÅÅµç»°ÃæÊÔ----±ÊÊÔ----·¢·Åoffer£¨Ð½³êºÍÈëְʱ¼ä£©---ÕýʽÈëÖ° Ö°ÎñÃèÊö£º Partners with the Clinical Study Team Lead to provide study level operational and logistical support to clinical study teams to ensure the timely and efficient execution of clinical trials and compliance with ICH-GCP, SOP, and regulatory requirements. Works proactively and independently to coordinate and prioritize multiple key study tasks in support of clinical trial systems and processes. Collaborates with global cross functional study team members of varying levels of seniority. Uses established procedures and methodologies to ensure the completion of assigned tasks according to timelines and to required quality standards. Has fundamental knowledge of the principles and concepts related to the CSTA role. [ À´×Ô°æ¿éȺ ºþ±± ] |
» ²ÂÄãϲ»¶
»ï°éÃÇ£¬×£ÎÒÉúÈÕ¿ìÀÖ°É
ÒѾÓÐ5È˻ظ´
274Çóµ÷¼Á0856²ÄÁÏ»¯¹¤
ÒѾÓÐ10È˻ظ´
337Ò»Ö¾Ô¸»ªÄÏÀí¹¤0805²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
£¨081700£©»¯Ñ§¹¤³ÌÓë¼¼Êõ-298·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏÓ뻯¹¤304ÇóBÇøµ÷¼Á
ÒѾÓÐ5È˻ظ´
NSFCÉ걨ÊéÀïÉêÇëÈ˼òÀúÖдú±íÐÔÂÛÖø»¹ÐèÒªÔÚÉ걨Êé×îºóµÄ¸½¼þÀïÃæÔÙÉÏ´«Ò»±éÂð
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ²ÄÁÏÓ뻯¹¤296·ÖÇóµ÷¼Á
ÒѾÓÐ17È˻ظ´
0703»¯Ñ§Ò»Ö¾Ô¸211 ×Ü·Ö320Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
0703Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸Ìì½ò´óѧ²ÄÁÏÓ뻯¹¤275Çóµ÷¼Á
ÒѾÓÐ22È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
ÉϺ£ÓÅÐãÄÐÉú³ÏÕ÷½á»éÅ®ÓÑ·ûºÏ΢ÐÅÁªÏµ
+3/769
ɽ¶«Õ÷Å®ÓÑ£¬×ø±ê¼ÃÄÏ
+1/164
º£ÄÏ´óѧÇñÌìÓîÀÏʦÍŶÓÕÐÊÕ²©Ê¿ÉúÓëÕÐÆ¸²©Ê¿ºó
+5/110
Àä¶³ÐÐÐÇÇòÄ¥»ú¡¢µÍθßÎÂÇòÄ¥»ú
+1/90
ÕÐÊÕµ÷¼ÁÉú£¬¶¯Îïҽѧ¡¢Ë®²úÑøÖ³¡¢Ë®²ú¶¯ÎïҽѧµÈרҵ
+1/88
²ÄÁÏ/»¯Ñ§Ïà¹Ø×¨Òµ2026¼¶Ñ§Êõ/רҵÐÍ˶ʿÑо¿Éú
+1/87
26µ÷¼Á
+1/36
н®´óѧÕÐÊÕѧ˶µ÷¼Á
+1/36
ÖпÆÔº»¯Ñ§Ëù ËÎÑÓÁÖ ¿ÎÌâ×éÕÐÆ¸ºÏ³É»¯Ñ§·½Ïò²©Ê¿ºó£¨¿ªÕ¹´òÓ¡ºÏ³É»¯Ñ§·½ÏòÑо¿£©
+1/34
ÃÀ¹úÃÜËÕÀï´óѧ¡°ÈáÐÔµç×Ó¡±¿ÎÌâ×é³ÏƸ²©Ê¿ºÍ²©Ê¿ºó
+1/25
¹ú¼ÒÄÉÃ׿ÆÑ§ÖÐÐÄÕÐÊÕÁªºÏÅàÑø²©Ê¿¼°²©Ê¿ºó
+1/17
ÖØÇì´óѧ³ÏÕÐ2026ÄêÉúÎï²ÄÁÏ·½Ïò²©Ê¿Éú
+1/16
½ðÒ»Õþ½ÌÊÚ¿ÎÌâ×éÕÐÆ¸Æ÷¼þ¹¤ÒÕ¹¤³ÌʦÆôÊÂ
+1/13
Çൺ¿Æ¼¼´óѧ0860 Ò»Ö¾Ô¸./µ÷¼Á ÕÐÉú
+1/10
¡¾²©Ê¿ºó/¿ÆÑÐÖúÀí ÕÐÆ¸-±±¾©Àí¹¤´óѧ-¼¯³Éµç·Óëµç×ÓѧԺ-¹ú¼Ò½ÜÇàÍŶӡ¿
+1/9
²©Ê¿ÕÐÉú-»¶Ó±¨¿¼2026ÄêÉÂÎ÷Ê¡ÖØµã¿ÆÑд´ÐÂÍŶӣ¨ÌÆÁؽÌÊÚ£©µÄ²©Ê¿/˶ʿÑо¿Éú£¡
+1/8
¡¾Éñ¾ÉúÎïѧ¿¼²©ÇóÖú¡¿
+1/8
ÖйúʯÓÍ´óѧ£¨±±¾©£©¹ú¼Ò¼¶´óÈ˲ÅÍŶӲ©Ê¿ÕÐÉú3Ãû£º»¯Ñ§¡¢²ÄÁÏ¡¢Ê¯Ó͹¤³Ì£ºÓÍÌﻯѧ
+1/4
ÖпÆÔºÌì½ò¹¤ÒµÉúÎï¼¼ÊõËùÓë¹þ¶û±õ¹¤Òµ´óѧÁªºÏ²©Ê¿ÕÐÉú2026
+1/2
¡¾²©Ê¿ÕÐÉú¡¿±±·½¹¤Òµ´óѧÕÐÊÕ »úе¹¤³Ì·½Ïò ÉêÇ뿼ºËÖÆ²©Ê¿
+1/1
29Â¥2021-06-12 12:32:01
4Â¥2021-05-25 17:30:06
ÏùÕŵij¬³¬
Ìú¸Ëľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 40 (СѧÉú)
- ½ð±Ò: 3396.8
- Ìû×Ó: 20848
- ÔÚÏß: 2802.1Сʱ
- ³æºÅ: 3860801
7Â¥2021-05-25 19:56:10
¼òµ¥»Ø¸´
dxmboy882Â¥
2021-05-25 17:28
»Ø¸´
bjdxyxy3Â¥
2021-05-25 17:29
»Ø¸´
redkey65(½ð±Ò+1): лл²ÎÓë
¡£ ·¢×ÔСľ³æAndroid¿Í»§¶Ë
ʯͷ°¢´ô5Â¥
2021-05-25 17:33
»Ø¸´
redkey65(½ð±Ò+1): лл²ÎÓë
. ·¢×ÔСľ³æIOS¿Í»§¶Ë
tzynew6Â¥
2021-05-25 17:34
»Ø¸´
redkey65(½ð±Ò+1): лл²ÎÓë
9 ·¢×ÔСľ³æAndroid¿Í»§¶Ë
nono20099Â¥
2021-05-25 20:40
»Ø¸´
redkey65(½ð±Ò+1): лл²ÎÓë
¡£ ·¢×ÔСľ³æAndroid¿Í»§¶Ë
Sleep1110Â¥
2021-05-25 20:59
»Ø¸´
redkey65(½ð±Ò+1): лл²ÎÓë
£¬ ·¢×ÔСľ³æIOS¿Í»§¶Ë
zhanglang9312Â¥
2021-05-25 23:45
»Ø¸´
redkey65(½ð±Ò+1): лл²ÎÓë
£¬ ·¢×ÔСľ³æAndroid¿Í»§¶Ë
yuanbingzhan14Â¥
2021-05-26 07:11
»Ø¸´













»Ø¸´´ËÂ¥